(RYE BROOK, NY, July 22, 2020) - The effects of the COVID-19 pandemic are far reaching, and high school students are among those whose lives are being up-ended. Not only is this generation missing many traditional rites of passage, but they are graduating into a frightening world and an uncertain future. Read More
The Leukemia & Lymphoma Society Announces Board of Directors Officer Appointments and Welcomes Four New MembersPosted On: July 19, 2020
RYE BROOK, NY, July 20, 2020 - The Leukemia & Lymphoma Society (LLS) announced today National Board Officer appointments and four new members to its National Board of Directors, who will work alongside LLS leadership to ensure that the organization continues to deliver its cancer curing mission and impact for patients, despite the challenges caused by the COVID-19 pandemic.Read More
One of the things that I value most about leading The Leukemia & Lymphoma Society (LLS) is seeing our talented, dedicated and relentless staff and volunteers in action. During these trying times, they have adapted and rallied behind our mission like never before.
The past few months have been extremely difficult for all of us at LLS. The COVID-19 pandemic and its impact on the economy has dealt a major setback to LLS’s ability to raise funds for our mission threatening the future of our organization at a time when blood cancer patients and families need us more than ever.Read More
LLS, The Mark Foundation for Cancer Research and The Paul G. Allen Frontiers Group Partner to Award $6.75M in New Grants to Drive the Next Wave of Novel Cancer TherapiesPosted On: June 30, 2020
(Rye Brook, NY, July 1, 2020) - Seeking to ignite the next major breakthroughs to treat blood cancers, The Leukemia & Lymphoma Society (LLS), The Mark Foundation, and The Paul G. Allen Frontiers Group today announced more than $6.75 million awarded to nine of the most exceptional scientists in the field.Read More
LLS Announces Collaboration with the National Cancer Institute and Children’s Oncology Group on a Global Master Clinical Trial for Children with Acute LeukemiaPosted On: June 17, 2020
June 17, 2020 (Rye Brook, NY) - The Leukemia & Lymphoma Society (LLS) announced today a collaboration with the National Cancer Institute (NCI) and the Children’s Oncology Group (COG) to launch a global precision medicine clinical trial for children with acute leukemia. The three organizations share a commitment to address the urgent need for new, more precise and more effective treatments for children with cancer.Read More
June 15, 2020 – Today 29 patient and consumer groups representing millions of people nationwide with pre-existing health conditions issued the following statement in response to administration’s final rule. The rule, finalized Friday, attempts to undermine Section 1557 of the Affordable Care Act by removing explicit protections against discrimination of patients by providers and institutions:Read More
NEW YORK, June 16, 2020 – Individuals and communities nationwide are tapping into their inner creativity and survival skills to pivot to a virtual way of living. A campaign developed by Engine Shop, a leading engagement marketing agency, will connect a community of generous gamers with the lifesaving work of The Leukemia & Lymphoma Society (LLS), a global leader in the fight against cancer.Read More
Please send all media-related inquiries and interview requests to email@example.com. An LLS representative will respond as soon as possible.